JP2009525478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009525478A5 JP2009525478A5 JP2008552858A JP2008552858A JP2009525478A5 JP 2009525478 A5 JP2009525478 A5 JP 2009525478A5 JP 2008552858 A JP2008552858 A JP 2008552858A JP 2008552858 A JP2008552858 A JP 2008552858A JP 2009525478 A5 JP2009525478 A5 JP 2009525478A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- prongf
- body fluid
- biological sample
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0600851A FR2896881B1 (fr) | 2006-01-31 | 2006-01-31 | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
| FR0600851 | 2006-01-31 | ||
| PCT/FR2007/050708 WO2007088305A1 (fr) | 2006-01-31 | 2007-01-30 | Procede de dosage du prongf pour le diagnostic in vitro du cancer en particulier du cancer du sein, de la thyroide ou du poumon et utilisation du prongf en therapie |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012124525A Division JP5792121B2 (ja) | 2006-01-31 | 2012-05-31 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009525478A JP2009525478A (ja) | 2009-07-09 |
| JP2009525478A5 true JP2009525478A5 (https=) | 2010-03-04 |
| JP5091876B2 JP5091876B2 (ja) | 2012-12-05 |
Family
ID=36741378
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552858A Active JP5091876B2 (ja) | 2006-01-31 | 2007-01-30 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
| JP2012124525A Active JP5792121B2 (ja) | 2006-01-31 | 2012-05-31 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012124525A Active JP5792121B2 (ja) | 2006-01-31 | 2012-05-31 | 癌、特に乳癌、甲状腺癌及び肺癌のインビトロ診断のためのＰｒｏＮＧＦアッセイのための方法とＰｒｏＮＧＦの治療的使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8008009B2 (https=) |
| EP (1) | EP1982192B1 (https=) |
| JP (2) | JP5091876B2 (https=) |
| CN (2) | CN103446585A (https=) |
| ES (1) | ES2471126T3 (https=) |
| FR (1) | FR2896881B1 (https=) |
| WO (1) | WO2007088305A1 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2896881B1 (fr) * | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| EP2806054A1 (en) | 2008-05-28 | 2014-11-26 | Genomedx Biosciences Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| FR2944019B1 (fr) * | 2009-04-03 | 2011-04-22 | Biomerieux Sa | Procede de dosage de la prodefensine-a6 pour le diagnostic in vitro du cancer colorectal. |
| US8669057B2 (en) | 2009-05-07 | 2014-03-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| CN101782585A (zh) * | 2010-02-10 | 2010-07-21 | 广州医学院 | 肺癌组织蛋白印迹膜片及其制备方法 |
| US20130115222A1 (en) * | 2010-06-15 | 2013-05-09 | Cornell University | Methods of limiting microvascular damage following acute myocardial ischemia |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| US20140295426A1 (en) * | 2011-07-28 | 2014-10-02 | Veridex Llc | Methods for Diagnosing Cancer by Characterization of Tumor Cells Associated with Pleural or Serous Fluids |
| EP2791359B1 (en) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| DK3435084T3 (da) | 2012-08-16 | 2023-05-30 | Mayo Found Medical Education & Res | Prostatakræftprognose under anvendelse af biomarkører |
| CN103122390B (zh) * | 2013-03-07 | 2015-04-08 | 上海市疾病预防控制中心 | Frat1基因作为检测甲状腺癌的血清标志物及其应用 |
| EP3626308A1 (en) | 2013-03-14 | 2020-03-25 | Veracyte, Inc. | Methods for evaluating copd status |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| CN103866039B (zh) * | 2014-04-04 | 2015-05-27 | 厦门大学 | 人类甲状腺癌组织基因特异位点甲基化水平检测引物及其应用 |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| EP2977759B1 (en) * | 2014-07-25 | 2017-07-12 | Serum Institute of India Private Limited | Highly sensitive immunoassay for rapid quantification of meningococcal capsular polysaccharide antigens |
| EP3215170A4 (en) | 2014-11-05 | 2018-04-25 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
| CN107708733B (zh) | 2015-04-07 | 2022-11-15 | 艾利妥 | 抗分拣蛋白抗体和其使用方法 |
| US10849992B1 (en) | 2015-04-07 | 2020-12-01 | Alector Llc | Methods of screening for sortilin binding antagonists |
| EP3504348B1 (en) | 2016-08-24 | 2022-12-14 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| EP3571322B9 (en) | 2017-01-20 | 2023-10-04 | VERACYTE SD, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| JP2020508643A (ja) * | 2017-01-24 | 2020-03-26 | ジェネティック テクノロジーズ リミテッド | 乳癌発症リスクの改良された評価法 |
| EP3593140A4 (en) | 2017-03-09 | 2021-01-06 | Decipher Biosciences, Inc. | SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY |
| CA3062716A1 (en) | 2017-05-12 | 2018-11-15 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| CA3066507A1 (fr) * | 2017-06-08 | 2018-12-13 | Carcidiag Biotechnologies | Methode d'isolement et de detection de cellules souches cancereuses |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| WO2019028285A2 (en) | 2017-08-04 | 2019-02-07 | Genomedx, Inc. | USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY |
| TWI809147B (zh) | 2018-07-13 | 2023-07-21 | 美商阿列克特有限責任公司 | 抗分揀蛋白抗體及其使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548062B2 (en) | 2000-02-29 | 2003-04-15 | Cephalon, Inc. | Method of treating cancer with anti-neurotrophin agents |
| AU2003242815A1 (en) | 2002-03-13 | 2003-09-22 | Biomerieux | Method for the characterisation of circulating tumour cells stemming from solid cancers |
| FR2846426B1 (fr) | 2002-10-28 | 2004-12-10 | Bio Merieux | Procede de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie |
| AU2003287930A1 (en) * | 2002-12-20 | 2004-07-14 | Neuronicon Aps | Modulation of activity of neurotrophins |
| WO2005076695A2 (en) * | 2004-02-11 | 2005-08-25 | Painceptor Pharma Corporation | Methods of modulating neurotrophin-mediated activity |
| FR2896881B1 (fr) * | 2006-01-31 | 2008-04-18 | Biomerieux Sa | Procede de dosage du prongf pour le diagnostic in vitro du cancer du sein et utilisation du prongf en therapie |
-
2006
- 2006-01-31 FR FR0600851A patent/FR2896881B1/fr not_active Expired - Fee Related
-
2007
- 2007-01-30 US US12/087,606 patent/US8008009B2/en active Active
- 2007-01-30 ES ES07731536.4T patent/ES2471126T3/es active Active
- 2007-01-30 JP JP2008552858A patent/JP5091876B2/ja active Active
- 2007-01-30 CN CN2013103889291A patent/CN103446585A/zh active Pending
- 2007-01-30 CN CN2007800040238A patent/CN101395478B/zh not_active Expired - Fee Related
- 2007-01-30 EP EP07731536.4A patent/EP1982192B1/fr active Active
- 2007-01-30 WO PCT/FR2007/050708 patent/WO2007088305A1/fr not_active Ceased
-
2011
- 2011-07-20 US US13/137,101 patent/US20110293636A1/en not_active Abandoned
-
2012
- 2012-05-31 JP JP2012124525A patent/JP5792121B2/ja active Active
- 2012-06-26 US US13/533,908 patent/US9061045B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009525478A5 (https=) | ||
| Wilmott et al. | Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma | |
| Houshmand et al. | Chronic myeloid leukemia stem cells | |
| Liu et al. | Deubiquitinase activity profiling identifies UCHL1 as a candidate oncoprotein that promotes TGFβ-induced breast cancer metastasis | |
| Mercer et al. | Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF | |
| Kelly et al. | The dynamic and transient immune microenvironment in locally advanced esophageal adenocarcinoma post chemoradiation | |
| Chen et al. | Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer | |
| Savas et al. | Clinical relevance of host immunity in breast cancer: from TILs to the clinic | |
| Syn et al. | NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease | |
| Wu et al. | Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo | |
| US9670550B2 (en) | Method for examination of carcinogenic risk | |
| US12352752B2 (en) | Application of Niemann-Pick C1 protein in diagnosis and treatment of cancer | |
| Chu et al. | Can determination of circulating endothelial cells and serum caspase-cleaved CK18 predict for response and survival in patients with advanced non–small-cell lung cancer receiving endostatin and paclitaxel–carboplatin chemotherapy? A Retrospective Study | |
| Wang et al. | The prediction of survival of patients with gastric cancer with PD-L1 expression using contrast-enhanced ultrasonography | |
| Dudek et al. | Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma | |
| Tarhini et al. | Operable melanoma: screening, prognostication, and adjuvant and neoadjuvant therapy | |
| US20090226901A1 (en) | Method of evaluating or selecting agents for preventing or improving pigmented spots | |
| CN112262157A (zh) | 化药抗性癌症的组合治疗 | |
| Dai et al. | Tumor vascular normalization by B7-H3 blockade augments T lymphocyte-mediated antitumor immunity | |
| US20210208161A1 (en) | CCL24 as a Diagnostic and Therapeutic Target for Breast Cancer | |
| FR2840905B1 (fr) | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers | |
| Ollila-Raj et al. | Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing | |
| RU2436102C1 (ru) | Способ прогнозирования метастазов рака шейки матки | |
| Robertson | THE PLANTAR MECHANICAL MICROENVIRONMENT PROMOTES PROLIFERATION AND INVASION OF ACRAL MELANOMAS | |
| He et al. | The Expression of PD-L1, CD47, CD4, and CD8 in Breast Cancer before and after Neoadjuvant Chemotherapy and Their Relationship with Clinicopathological Features and Prognosis |